/
ACUC.ST
No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
AcuCort AB
Specializing in pharmaceutical innovation, AcuCort AB (publ) focuses on the development and commercialization of glucocorticoid dexamethasone film products, particularly for acute allergic conditions. Among its offerings is Zeqmelit, a medication with diverse therapeutic uses. Zeqmelit addresses severe and acute allergic reactions, pediatric croup, chemotherapy-induced nausea and vomiting, and also serves as a treatment for COVID-19 patients who require supplemental oxygen. The company, established in 2006, is headquartered in Lund, Sweden.
www.acucort.se- Employees
- 5
- IPO / List date
- Apr 24, 2017
- HQ
- SE
Held by traders on TradeandTell
No one on the platform currently holds ACUC.ST.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ACUC.ST as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ACUC.ST yet.